– USA, CO – Healthpeak Properties, Inc. (NYSE: PEAK) today announced the appointment of Kathy Sandstrom as Independent Chair of the Board of Directors, succeeding Brian Cartwright, who will continue to serve on the Board as an Independent Director.
Scott Brinker, President, and CEO said, “I am excited to partner with Kathy in her new role as we advance the Company’s strategic initiatives.”
About Kathy Sandstrom
Kathy Sandstrom has over 20 years of real estate finance and investment experience. She served as Senior Managing Director and global head of Heitman LLC’s Public Real Estate Securities business from 2013 to 2018. She was a member of the firm’s Global Management Committee, the Board of Managers, and the Allocation Committee. Since joining Heitman in 1996, Ms. Sandstrom held several senior leadership positions in multiple roles in the institutional real estate investment industry. She has served on Healthpeak’s Board since 2018 and as Vice-Chair since 2022 and is a member of the boards of directors of EastGroup Properties, Inc. and Urban Edge Properties, both NYSE-listed REITs. Ms. Sandstrom is also a certified public accountant.
Ms. Sandstrom said, “I am fortunate to follow in the footsteps of a gifted Board Chair who has fostered a collegial and disciplined Board culture. I look forward to leading the Board as it provides guidance and oversight to the experienced and highly energized team led by Scott Brinker.”
About Healthpeak Properties, Inc.
Healthpeak Properties, Inc. is a fully integrated real estate investment trust and S&P 500 company. Healthpeak owns, operates, and develops high-quality healthcare real estate focused on the aging population and the desire for improved health.
Source: https://www.healthpeak.com/
- Disclaimer - News, data, and statements included in this release are intended exclusively for general information purposes. Talent4Boards does not guarantee that news is accurate or about the correct person and accepts neither liability for the consequences of the reader’s reliance, nor responsibility for the accuracy of the information. Nothing in this release should be considered for decisions about referred securities. Products and brand names may be trademarks or registered trademarks of their respective owners.